Dept of Health Abu Dhabi and Pfizer Partner To Research in Sickle Cell Disease

During the BIO 2024 International Convention, the Department of Health – Abu Dhabi (DoH), the Emirate's healthcare regulator, entered into a Memorandum of Understanding (MoU) with Pfizer Gulf FZ LLC, a global pharmaceutical firm...

Nu-Tek BioSciences Inks Pact with IMCD for Distribution

Nu-Tek BioSciences is an innovative developer of crucial raw materials used in cell culture media for pharmaceutical development and production. Nu-Tek has signed an agreement with IMCD to distribute its peptones and hydrolysates throughout Europe...

QurAlis Corp Forays Into Agreement with Eli Lilly To Develop QRL-204

QurAlis Enterprise (QurAlis) reported that it has gone into a exclusive license agreement with Eli Lilly and Company (Lilly) in which QurAlis is conceding Lilly worldwide privileges to create and popularize QRL-204, a possibly top tier splice...

Aurigene Announces the Opening of Its Biologics Facility

Aurigene Pharmaceutical Services Limited (“Aurigene”), a Dr. Reddy’s Laboratories Limited company, inaugurated its biologics facility spread across 70,000 sq.ft.in Genome Valley, a bio cluster, located in Hyderabad, India. The facility is designed...

BD to Acquire Edwards Lifescience's Critical Care Product Group

BD (Becton, Dickinson and Company), a main worldwide medical technology firm, and Edwards Lifesciences reported a conclusive arrangement under which BD will buy Edwards' critical Care product group (Critical Care), a worldwide forerunner in...

Massive Bio and Un Ensayo Para Mi Team up to Transform Oncology Clinical Trial

Massive Bio, an international leader in AI-driven oncology solutions, and Un Ensayo Para Mi (UEPM), Latin America's foremost clinical trial search portal, are pleased to announce an expanded collaboration. This agreement will expand Massive Bio's...

© 2024 India Pharma Outlook. All Rights Reserved.